IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 14, 2019

Primary Completion Date

October 8, 2019

Study Completion Date

November 18, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

IMCY-0098 or placebo

Long-term follow-up

Trial Locations (19)

Unknown

Hôpital Erasme, Brussels

UZ Brussel, Brussels

UZ Gent, Ghent

Bispebjerg and Frederiksberg Hospital, Copenhagen

Hôpital Cochin, Paris

GWT-TUD GmbH, Dresden

Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), München

Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas

Klaipeda University Hospital, Klaipėda

University Hospital Santaros Klinikos, Vilnius

Clinical Trial Center, CTC, Gothenburg

ProbarE Stockholm, Stockholm

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Cardiff University, Cardiff

Royal Devon and Exeter NHS Trust, Exeter

Guy's and St. Thomas NHS Trust, London

St. Bartholomew's Hospital (Barts Health NHS Trust), London

Newcastle University, Newcastle upon Tyne

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Imcyse SA

INDUSTRY

NCT04190693 - IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo | Biotech Hunter | Biotech Hunter